2020
DOI: 10.1093/jcag/gwz047.156
|View full text |Cite
|
Sign up to set email alerts
|

A157 the Effectiveness of a Standardized Biologic Care Pathway in the Management and Treatment of Inflammatory Bowel Disease

Abstract: Background Inflammatory Bowel Disease (IBD) is a class of chronic immune-mediated diseases. Biologics have revolutionized the treatment of IBD. Existing literature suggests significant variation exists in the use of biologic treatment among physicians, from provider-specific prescribing to completion of the pre-biologic workup. These differences may influence the effectiveness of achieving and maintaining long-term remission. Clinical care pathways may serve to standardize the use of biologic… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles